[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@_OliverVenture Avatar @_OliverVenture Oliver Venture

Oliver Venture posts on X about $nams, $odd, $ntla, $beam the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence cryptocurrencies XXXX% stocks XXXX% technology brands XXXX% finance XXXX% travel destinations XXXX%

Social topic influence $nams #8, $odd 1.92%, $ntla #18, $beam #65, $prme #22, $mgx #2, influencers 0.96%, beef 0.96%, socials 0.96%, all the XXXX%

Top accounts mentioned or mentioned by @longoption @jessiechimni @planetoptimism @biomedicalrx @bigfatsurprise @corbeiljb @templedietitian @bukvarevicedim @bulkbiker @smartfinapp @samdavisesq @ny1972_47 @quartrapp @kendberrymd @fitfounder @pierrekory @midwesterndoc @drmakaryfda @megynkelly @marion436842126

Top assets mentioned NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) ODDITY Tech Ltd. Class A Ordinary Shares (ODD) Intellia Therapeutics, Inc (NTLA) BEAM (BEAM) Certara, Inc. Common Stock (CERT) Palantir (PLTR) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Schrodinger, Inc. Common Stock (SDGR) Muhdo Hub (DNA) Bitcoin Incognito (XBI) CRISPR Therapeutics AG (CRSP) Hims & Hers Health, Inc. (HIMS)

Top Social Posts #

Top posts by engagements in the last XX hours

"Reality: Less than 10% follow the guidelines. The ones that do have better health outcomes than the ones that don't. Factually the correction needed is getting the XX% of Americans on the standard american diet or worse (keto/lchf/carnivore) to follow the evidence based guidelines"
X Link @_OliverVenture 2025-10-16T18:11Z 1395 followers, XXX engagements

"Yeah we have elevated ldl evidence too and it's also bad (CVD leading cause of death). Keto-CTA is great at showing the "healthiness" of the final form advocated by keto/carnivore influencers. Instantly deletes the magical thinking (but ratios but hdl but particle size but beef but .)"
X Link @_OliverVenture 2025-10-16T15:52Z 1395 followers, XX engagements

"LOL You've explained exactly why we don't need excess serum cholesterol (the body makes all it needs) but you also don't realize it Are babies short on LDL (avg 30-50) LOL Are our natural levels (50-80) too low Evolution disagrees and no one (on round earth) thinks so All the lines of evidence vs a few grifters on the socials just stick with the evidence"
X Link @_OliverVenture 2025-10-16T17:04Z 1395 followers, XX engagements

"$ODD A recent addition the premise is simple: 🐻The market sees makeup fashion fads and competition. 🐂The reality is a company leveraging a data lake of billions of data points courtesy of AI and XX million users. Makeup was just step one. The real product is the repeatable (now proven) data-driven process for building new brands. ⚡This morning Oddity released strong and IMO unsurprising earnings assuming you've listened to literally any other previous call. but. Oddity oddly tanked because of . EBITDA margins CFO Lindsay Drucker Mann: "Adjusted EBITDA margin of XXXX% compressed by around"
X Link @_OliverVenture 2025-08-06T01:46Z 1394 followers, XXX engagements

"Ranking "The Palantir of Biotech" (or adjacent) in order of closest to something like a $PLTR model it's a stretch I know X. Recursion $RXRX X. Abcellera $ABCL X. Schrdinger $SDGR X. Relay $RLAY X. Ginkgo $DNA X. Certara $CERT Completely unclear: the benefit of being the PLTR of $XBI given the comically long timeframes (imagine $PLTR's business over the same timeframe it takes a company to move a program from discovery to approval: 10-15 years. Cut in half if you want still absurd)"
X Link @_OliverVenture 2025-10-05T20:29Z 1394 followers, 2631 engagements

"$ARKG #CRISPR $NTLA $BEAM $CRSP $PRME Dude we're not even at '24 levels let alone 2020-21"
X Link @_OliverVenture 2025-10-12T23:20Z 1395 followers, 1228 engagements

"$NAMS why the stock didn't move. X. Preventive neurology is not (barely) a thing. X. P-tau217 is not a biomarker the FDA will accept as a single surrogate endpoint minus cognitive outcome data (which would take too long). X. Thus the path and timeline for an AD indication appears to be long expensive and uncertain. why it should move: X. The reduction in p-tau217 for the most at-risk cohort from obicetrapib was "comparable to that seen with anti-amyloid monoclonal antibodies in interventional trials." except achieved with a low dose pill with a well established safety profile remarkably"
X Link @_OliverVenture 2025-08-01T01:54Z 1394 followers, XXX engagements

"This is crazy. $NAMS"
X Link @_OliverVenture 2025-07-30T23:24Z 1394 followers, 2571 engagements

"Portfolio is having a totally normal one today. $SANA $HIMS $NTLA $NAMS $BEAM"
X Link @_OliverVenture 2025-10-15T18:56Z 1395 followers, XXX engagements

"CNBC talks about MGX a UAE investment co and unrelated $MGX gets halted. LOL. Efficient markets and what not"
X Link @_OliverVenture 2025-10-16T15:45Z 1395 followers, 1365 engagements

"Some of these non-commercial biotechs are so far away from phase X that they could round trip from highs to lows more than a few times. $MGX $PRME"
X Link @_OliverVenture 2025-10-08T22:32Z 1395 followers, 1945 engagements

"$NAMS Everyone rotating into (checks notes) CETP inhibitors today. 😆"
X Link @_OliverVenture 2025-10-10T20:09Z 1395 followers, XXX engagements

"$NAMS New Amsterdam Pharma hit all time highs. XXX% gain for a moment. Not bad for (checks notes) a CETP inhibitor"
X Link @_OliverVenture 2025-10-06T14:01Z 1394 followers, 1331 engagements

"$NAMS "I and my colleagues also I don't think we expected such a huge effect that we are now observing. That combined with the fact that this is an absolute safe drug has been tested in so many patients already and has no significant side effects really opens the door to thinking about the application of obacitropib at a very early stage in people who carry the APOE4 gene who have the highest risk for for progression and developing AD at a very early stage to take obicetrapib delay the onset of AD pathology delay the onset of dementia symptoms and dependence on others." One of the KOLs from"
X Link @_OliverVenture 2025-07-30T18:36Z 1394 followers, XXX engagements

"@BukvarevicEdim @bigfatsurprise No literally less than 10%. XX% following the standard american diet or worse (keto carnivore etc)"
X Link @_OliverVenture 2025-10-15T19:15Z 1394 followers, XX engagements

"Added to $ODD position"
X Link @_OliverVenture 2025-10-09T18:13Z 1395 followers, XXX engagements

"Actually converging lines of evidence support my position. Biological plausibility Mechanistic animal epidemiology rcts and of course genetic evidence. All lines of evidence in complete agreement. LDLs of 50-80 are what hunter and gatherers have (humans in the wild). Neonates 30-50. People lucky enough to have genetically low LDL are at 15-30. We're primates. We all have naturally low LDL. Our evolutionary baseline LDL isn't average LDL a few years before statins LOL I mean huh We now know because of the aforementioned converging evidence that LDLs above our natural levels the thresholds lead"
X Link @_OliverVenture 2025-10-16T23:51Z 1395 followers, XX engagements